These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3547859)

  • 21. Synergistic immunosuppressive effect of low-dose cyclosporine A and the calcium antagonist nifedipine, mediated by the generation of suppressor cells.
    Padberg WM; Bodewig C; Schäfer H; Muhrer KH; Schwemmle K
    Transplant Proc; 1990 Oct; 22(5):2337. PubMed ID: 2145676
    [No Abstract]   [Full Text] [Related]  

  • 22. Synergism of (15 S)-15-methyl-prostaglandin E1 with either azathioprine or prednisolone on the survival of heart allografts in rats.
    Kort WJ; Bonta IL; Adolfs MJ; Westbroek DL
    Prostaglandins Leukot Med; 1982 Jun; 8(6):661-4. PubMed ID: 7051048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of the timing of antigen administration on synergistic immunosuppression with cyclosporine.
    Yoshimura N; Kahan BD
    Transplantation; 1985 Jul; 40(1):108-10. PubMed ID: 3892789
    [No Abstract]   [Full Text] [Related]  

  • 24. Is cyclosporine A-induced nephrotoxicity in recipients of renal allografts progressive?
    Thiel G; Mihatsch M; Landmann J; Hermle M; Brunner FP; Harder F
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):169-78. PubMed ID: 3895657
    [No Abstract]   [Full Text] [Related]  

  • 25. Cardiac transplantation with low-dose ciclosporin and azathioprine and minimal or no oral steroids.
    Konertz W; Weyand M; Friedl A; Semik M; Bernhard A
    Bibl Cardiol; 1988; (43):156-8. PubMed ID: 3067716
    [No Abstract]   [Full Text] [Related]  

  • 26. Cardiac allograft tolerance induction with limited immunosuppression.
    Cohen DS; Fisher RA; Tarry WC; Tawes JW
    J Surg Res; 1996 Mar; 61(2):355-60. PubMed ID: 8656608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of the in vitro and in vivo immunosuppressive activity of brequinar sodium.
    Eiras-Hreha G; Cramer DV; Cajulis E; Cosenza C; Mills L; Hough K; Frankland M; Chapman F; Wang H; Zajac I
    Transplant Proc; 1993 Feb; 25(1 Pt 1):708-9. PubMed ID: 8438448
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immunosuppressive therapy with low cyclosporin A doses in rats].
    Klika T; Poledne R; Havlícková J
    Z Exp Chir Transplant Kunstliche Organe; 1989; 22(5):293-7. PubMed ID: 2588747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the effect of a 5-mg/kg and 10-mg/kg cyclosporine loading dose with single and multiple donor-specific transfusions on rat cardiac allograft survival.
    Fisher RA; Cohen DS; Alexander JW; Davies CB; Schroeder TJ
    Transplant Proc; 1994 Oct; 26(5):3056-9. PubMed ID: 7940961
    [No Abstract]   [Full Text] [Related]  

  • 30. Intravenous cyclosporine to induce immunosuppression in cardiac allograft recipients.
    Macris MP; Frazier OH; Van Buren CT; Duncan JM
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):311-5. PubMed ID: 3291261
    [No Abstract]   [Full Text] [Related]  

  • 31. Survival and function of peripheral nerve allografts after cessation of long-term cyclosporin immunosuppression in rats.
    Yu LT; England J; Hickey WF; Sumner A; Rhee E; Rostami A; Larossa D
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3178-80. PubMed ID: 2784925
    [No Abstract]   [Full Text] [Related]  

  • 32. Cyclosporine A prolonged survival time of parathyroid gland allograft in rats.
    He X; Zhu Y
    Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(3):160-2. PubMed ID: 2098769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of RS-61443 on antibody-mediated rejection.
    Knechtle SJ; Wang J; Burlingham WJ; Beeskau M; Subramanian R; Sollinger HW
    Transplantation; 1992 Mar; 53(3):699-701. PubMed ID: 1549873
    [No Abstract]   [Full Text] [Related]  

  • 34. Combined immunosuppressive therapy with cyclosporin A and azathioprine. A synergistic effect in three of four experimental models.
    Squifflet JP; Sutherland DE; Rynasiewicz JJ; Field J; Heil J; Najarian JS
    Transplantation; 1982 Dec; 34(6):315-8. PubMed ID: 6818737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Results of "immunoconversion" from cyclosporine to azathioprine in heart transplant recipients with progressive nephrotoxicity.
    Hunt SA; Stinson EB; Oyer PE; Billingham ME; Gamberg P; Miller J; Schroeder JS; Baldwin JC; Shumway NE
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2522-4. PubMed ID: 3274554
    [No Abstract]   [Full Text] [Related]  

  • 36. Induction of long-term graft tolerance and donor/recipient chimerism.
    Fisher RA; Cohen DS; Ben-Ezra JM; Sallade RE; Tawes JW; Tarry WC
    J Surg Res; 1996 Jan; 60(1):181-5. PubMed ID: 8592412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic interaction between anti-IFN alpha/beta antibody and low doses of cyclosporine therapy prolongs heart transplants in rats.
    Militerno G; Gugenheim J; Cuomo O; Hofman P; Mouiel J; Tovey M
    Transplant Proc; 1994 Oct; 26(5):3050-1. PubMed ID: 7940958
    [No Abstract]   [Full Text] [Related]  

  • 38. A comparison among the effects of donor-specific whole blood, bone marrow, and spleen leukocytes on allograft survival when combined with cyclosporine.
    Gyopar AF; Loertscher R; Guttman RD; Tchervenkov JI
    Transplantation; 1993 May; 55(5):1199-202. PubMed ID: 8497904
    [No Abstract]   [Full Text] [Related]  

  • 39. Reversal of experimental small bowel transplantation rejection with cyclosporine A.
    Liu Q; Yang R; Grosfeld JL; Collins MH; Pescovitz MD
    Transplant Proc; 1996 Oct; 28(5):2508-9. PubMed ID: 8907925
    [No Abstract]   [Full Text] [Related]  

  • 40. A new rat infection-heart transplant model: effect of infection on graft survival studies.
    Kobayashi J; Mavroudis C; Crawford SE; Zales VR; Backer CL
    J Heart Lung Transplant; 1993; 12(4):659-64. PubMed ID: 7690253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.